Thyroid cancer is a rare but important entity to watch out for, as it can affect an essential gland in the endocrine system, responsible for producing hormones that regulate the body's metabolism. The disease is characterised by the formation of malignant tumours in thyroid cells, which can develop from epithelial cells, parafollicular cells or C cells.

The main forms of thyroid cancer are papillary carcinoma, follicular carcinoma, medullary carcinoma and anaplastic carcinoma. Each of these variants differs in its histological features and clinical behaviour.

Thyroid cancer is generally diagnosed at a late stage, as it can present without long-term symptoms, and although it can occur at any age, it is often diagnosed in individuals between the ages of 30 and 50. Although generally considered to be a slow-growing cancer with a relatively favourable prognosis, thyroid cancer can sometimes present treatment challenges. The precise factors that trigger the development of this cancer often remain complex, involving both genetic and environmental influences. A thorough understanding of the cellular and molecular biology of this cancer is essential for developing more precise diagnostic and treatment strategies. Research continues to explore these aspects to better understand the pathogenesis of thyroid cancer, paving the way for innovative therapeutic approaches.

Select one of the products below to find the most commonly used cell lines for each of the specified cell types.